Dermal Fillers
YVOIRE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11241
Yvoire Y-Solution 720
In stock
Volume
1. x 1 mL
Laboratory
LG Chem
Origin
South Korea
Indication
Anti-ageing correction with projection and flexibility
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Yvoire Y-Solution 720 is a cross-linked hyaluronic acid dermal filler with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution line. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that support projection, flexibility and resistance to the movement of facial expressions. This reference contains 20 mg/mL of cross-linked hyaluronic acid, the highest concentration in the Y-Solution line documented so far, and is supplied as a single 1 mL syringe with two Terumo thin-wall 27G needles enclosed. It is CE-marked and intended for professional use by qualified practitioners only.
Key Benefits of Yvoire Y-Solution 720
- Combines high elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides projection with flexibility, designed to resist the dynamics of facial expression
- Contains cross-linked hyaluronic acid at 20 mg/mL with 0.3% lidocaine
- Supports anti-ageing aesthetic treatment
- The most concentrated Y-Solution reference documented in the range, against 12 mg/mL for Y-Solution 360
- Supplied with two Terumo thin-wall 27G needles
- CE-marked medical device
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring elasticity, cohesion and resistance to facial movement
Professional use
Yvoire Y-Solution 720 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. Two Terumo thin-wall 27G needles are enclosed, a heavier gauge than the 29G supplied with Y-Solution 360, consistent with a more concentrated gel at 20 mg/mL. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. The injection plane and specific treatment zones are not stated in the documentation held on file and must be taken from the manufacturer's Instructions for Use. Injection technique and volume per treatment area are determined by the practitioner.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction with projection that holds through facial movement, as assessed by a qualified practitioner. At 20 mg/mL this is a firmer gel than Y-Solution 360, so it suits cases needing more support, while patients wanting the lightest option in the line are better served by the 360 reference. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates. Patient selection follows the manufacturer's Instructions for Use.
How Yvoire Y-Solution 720 Works
The Yvoire 720 filler works through cross-linked hyaluronic acid at 20 mg/mL, formulated for what the manufacturer describes as a synergy between high elasticity and cohesion. The intended behaviour is spring-like: the gel holds projection while still flexing with the face, which is what the Y-Solution line is positioned around rather than static filling. At 20 mg/mL it is the firmer end of the line compared with the 12 mg/mL of Y-Solution 360, and the two Terumo thin-wall 27G needles enclosed reflect that difference in body. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Yvoire Y-Solution 720 differ from Yvoire Y-Solution 360?
Both sit in the same Y-Solution line and share the elasticity and cohesion concept, and both contain 0.3% lidocaine. The 720 reference is documented at 20 mg/mL cross-linked hyaluronic acid and supplied with 27G needles; the 360 reference is documented at 12 mg/mL and supplied with 29G needles. Each figure comes from that product's own documentation.
Which areas can be treated with Yvoire Y-Solution 720?
The manufacturer lists anti-ageing aesthetic treatment, facial projection support, and treatments requiring elasticity, cohesion and resistance to facial movement. Specific treatment zones are not named in the documentation held on file .
Does Yvoire Y-Solution 720 contain lidocaine?
Yes. The documentation specifies 0.3% lidocaine alongside 20 mg/mL of cross-linked hyaluronic acid. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
Which needles are supplied with Yvoire Y-Solution 720?
Two Terumo thin-wall 27G needles are enclosed, alongside a single 1 mL syringe.
How long do the results of Yvoire Y-Solution 720 last?
No duration is published in the documentation held on file. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks, but that is a published study rather than a manufacturer durability claim .
Is Yvoire Y-Solution 720 CE-marked?
Yes. The documentation states that the product is CE-marked and classifies it as medical. The device class and Notified Body are not published in that documentation .
More from LG Chem
Clinic alternatives
Mesotherapy
Skin Boosters
/ Recently viewed
Pick up where you left off
Yvoire Y-Solution 720
In stock
CE Marked
Yvoire Y-Solution 720 is a cross-linked hyaluronic acid dermal filler with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution line. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that support projection, flexibility and resistance to the movement of facial expressions. This reference contains 20 mg/mL of cross-linked hyaluronic acid, the highest concentration in the Y-Solution line documented so far, and is supplied as a single 1 mL syringe with two Terumo thin-wall 27G needles enclosed. It is CE-marked and intended for professional use by qualified practitioners only.
Key Benefits of Yvoire Y-Solution 720
- Combines high elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides projection with flexibility, designed to resist the dynamics of facial expression
- Contains cross-linked hyaluronic acid at 20 mg/mL with 0.3% lidocaine
- Supports anti-ageing aesthetic treatment
- The most concentrated Y-Solution reference documented in the range, against 12 mg/mL for Y-Solution 360
- Supplied with two Terumo thin-wall 27G needles
- CE-marked medical device
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring elasticity, cohesion and resistance to facial movement
Professional use
Yvoire Y-Solution 720 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. Two Terumo thin-wall 27G needles are enclosed, a heavier gauge than the 29G supplied with Y-Solution 360, consistent with a more concentrated gel at 20 mg/mL. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. The injection plane and specific treatment zones are not stated in the documentation held on file and must be taken from the manufacturer's Instructions for Use. Injection technique and volume per treatment area are determined by the practitioner.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction with projection that holds through facial movement, as assessed by a qualified practitioner. At 20 mg/mL this is a firmer gel than Y-Solution 360, so it suits cases needing more support, while patients wanting the lightest option in the line are better served by the 360 reference. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates. Patient selection follows the manufacturer's Instructions for Use.
How Yvoire Y-Solution 720 Works
The Yvoire 720 filler works through cross-linked hyaluronic acid at 20 mg/mL, formulated for what the manufacturer describes as a synergy between high elasticity and cohesion. The intended behaviour is spring-like: the gel holds projection while still flexing with the face, which is what the Y-Solution line is positioned around rather than static filling. At 20 mg/mL it is the firmer end of the line compared with the 12 mg/mL of Y-Solution 360, and the two Terumo thin-wall 27G needles enclosed reflect that difference in body. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Yvoire Y-Solution 720 differ from Yvoire Y-Solution 360?
Both sit in the same Y-Solution line and share the elasticity and cohesion concept, and both contain 0.3% lidocaine. The 720 reference is documented at 20 mg/mL cross-linked hyaluronic acid and supplied with 27G needles; the 360 reference is documented at 12 mg/mL and supplied with 29G needles. Each figure comes from that product's own documentation.
Which areas can be treated with Yvoire Y-Solution 720?
The manufacturer lists anti-ageing aesthetic treatment, facial projection support, and treatments requiring elasticity, cohesion and resistance to facial movement. Specific treatment zones are not named in the documentation held on file .
Does Yvoire Y-Solution 720 contain lidocaine?
Yes. The documentation specifies 0.3% lidocaine alongside 20 mg/mL of cross-linked hyaluronic acid. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
Which needles are supplied with Yvoire Y-Solution 720?
Two Terumo thin-wall 27G needles are enclosed, alongside a single 1 mL syringe.
How long do the results of Yvoire Y-Solution 720 last?
No duration is published in the documentation held on file. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks, but that is a published study rather than a manufacturer durability claim .
Is Yvoire Y-Solution 720 CE-marked?
Yes. The documentation states that the product is CE-marked and classifies it as medical. The device class and Notified Body are not published in that documentation .
More from LG Chem
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.